A new small molecule acceptor named BP-4F is developed. The optimal PSC based PM6:BP-4F achieves an excellent average PCE of 13.9% with an E loss of 0.59 eV and outstanding stability.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: